EIP
BIIB icon

Epoch Investment Partners’s Biogen BIIB Stock Holding History

Epoch Investment Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,058
Closed -$245K – 371
2024
Q2 		$245K Sell
1,058
-281
-21% -$61.1K ﹤0.01% 373
2024
Q1 		$289K Sell
1,339
-275,885
-100% -$64.6M ﹤0.01% 389
2023
Q4 		$71.7M Buy
277,224
+91,178
+49% +$22.4M 0.33% 110
2023
Q3 		$47.8M Sell
186,046
-16,970
-8% -$4.54M 0.3% 113
2023
Q2 		$57.8M Sell
203,016
-7,160
-3% -$2.13M 0.33% 101
2023
Q1 		$58.4M Sell
210,176
-11,425
-5% -$3.16M 0.35% 92
2022
Q4 		$61.4M Buy
221,601
+7,803
+4% +$2.2M 0.37% 90
2022
Q3 		$57.1M Sell
213,798
-5,809
-3% -$1.23M 0.37% 93
2022
Q2 		$44.8M Buy
219,607
+38,681
+21% +$7.91M 0.26% 133
2022
Q1 		$38.1M Buy
+180,926
New +$39.3M 0.19% 156
2019
Q1 		– Sell
-18,280
Closed -$5.5M – 307
2018
Q4 		$5.5M Buy
18,280
+490
+3% +$156K 0.03% 237
2018
Q3 		$6.29M Sell
17,790
-6,550
-27% -$2.26M 0.02% 242
2018
Q2 		$7.06M Buy
24,340
+17,007
+232% +$4.78M 0.02% 237
2018
Q1 		$2.01M Buy
7,333
+76
+1% +$23.6K 0.01% 276
2017
Q4 		$2.31M Buy
7,257
+95
+1% +$30.5K 0.01% 269
2017
Q3 		$2.24M Buy
7,162
+100
+1% +$29.6K 0.01% 270
2017
Q2 		$1.92M Hold
7,062
– – 0.01% 274
2017
Q1 		$1.93M Hold
7,062
– – 0.01% 276
2016
Q4 		$2M Buy
7,062
+2,101
+42% +$623K 0.01% 250
2016
Q3 		$1.55M Buy
4,961
+1,073
+28% +$318K 0.01% 259
2016
Q2 		$940K Sell
3,888
-6,513
-63% -$1.72M ﹤0.01% 267
2016
Q1 		$2.71M Sell
10,401
-2
-0% -$528 0.01% 210
2015
Q4 		$3.19M Buy
+10,403
New +$2.99M 0.01% 200

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Epoch Investment Partners's BIIB Position: Q3 2024 in Review

Epoch Investment Partners sold out of Biogen (BIIB) in Q3 2024, closing a stake of 1,058 shares — an estimated $245K sold.

Epoch Investment Partners first reported a position in BIIB in Q4 2015 and held it in 23 quarters. The position peaked at $71.7M in Q4 2023. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Epoch Investment Partners reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Epoch Investment Partners sold 1,058 Biogen shares in Q3 2024, an estimated $245K.
  • Epoch Investment Partners first reported a position in Biogen in Q4 2015 and held it in 23 quarters.
  • Epoch Investment Partners's Biogen position peaked at $71.7M in Q4 2023.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Epoch Investment Partners's 13F filing for Q3 2024, filed 13 Nov 2024.